Understanding the Treatment and Recovery Time of Newborn Hemolytic Disease

Learn how to interpret the prenatal test report for newborn hemolytic disease, particularly regarding the compatibility issues of ABO hemolysis and RH negative blood.

Newborn hemolytic disease test results show occasional findings of macrophages, and it is recommended to actively treat to prevent the occurrence of jaundice.

O-type RH positive mothers and B-type blood fathers should be aware of the risk of newborn ABO hemolytic disease during pregnancy.

Learn about the causes, symptoms, and treatment methods of ABO hemolytic disease of the newborn, as well as the impact on newborns when the mother’s and baby’s ABO blood types do not match.

Newborn hemolytic disease refers to incompatibility between the mother and baby’s blood types, where the mother’s blood contains immune antibodies IgG against the fetus’s red blood cells, which pass through the placenta into the fetal circulation, causing a cross-reactive immune response that leads to the destruction of fetal and newborn red blood cells and resulting in hemolysis. Pre-natal treatment can include plasma exchange in pregnant women, intrauterine transfusion, and consideration of early delivery; post-natal treatment includes blood transfusion therapy, phototherapy, correcting anemia, and symptomatic treatment. Additionally, active treatment and management for jaundice are necessary to prevent complications.